Alembic Pharmaceuticals informs about annual secretarial compliance report

10 May 2021 Evaluate

Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, Alembic Pharmaceuticals has informed that it has enclosed the Annual Secretarial Compliance Report issued by Samdani Shah & Kabra, Practicing Company Secretaries, for the financial year ended 31st March, 2021.

The above information is a part of company’s filings submitted to BSE.



Alembic Pharma Share Price

773.55 10.65 (1.40%)
23-Feb-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1733.75
Dr. Reddys Lab 1303.95
Cipla 1326.10
Zydus Lifesciences 908.85
Lupin 2250.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×